[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353350-105":59,"doc-detail-353350-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","molecular-mechanisms-of-bacteria-mediated-cancer-immunotherapy-from-intratumoral-microbiota-to-engineered-therapeutics","Molecular mechanisms of bacteria-mediated cancer immunotherapy - from intratumoral microbiota to engineered therapeutics","","Immunotherapy has reshaped oncology, yet its effectiveness is limited by low response rates, primary or acquired resistance, immune-related toxicities, and rising costs. This Review synthesizes molecular insights into how bacteria-mediated cancer immunotherapy exploits intratumoral microbiota as a programmable therapeutic platform. It explains mechanisms by which intratumoral bacteria enhance or suppress tumors, including genotoxicity, epigenetic reprogramming, metabolic competition, and tumor-immune interface modulation. It also evaluates engineered delivery strategies and translational barriers, proposing an AI-guided microbiome-integrated framework to accelerate clinical translation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-mechanisms-of-bacteria-mediated-cancer-immunotherapy-from-intratumoral-microbiota-to-engineered-therapeutics/353350/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-mechanisms-of-bacteria-mediated-cancer-immunotherapy-from-intratumoral-microbiota-to-engineered-therapeutics/353350.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What limits the effectiveness of cancer immunotherapy addressed in the Review?","Question",{"text":113,"@type":114},"The Review highlights low response rates, primary or acquired resistance, immune-related toxicities, and escalating costs as key constraints.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do intratumoral bacteria influence cancer and the immune environment?",{"text":118,"@type":114},"They can enhance or suppress malignancy through pathways including genotoxicity, epigenetic reprogramming, metabolic competition, and modulation of the tumor-immune interface.",{"name":120,"@type":111,"acceptedAnswer":121},"What engineering approaches does the Review discuss for bacterial-based immunotherapy?",{"text":122,"@type":114},"It discusses engineering strategies such as quorum-sensing circuits, thermo-inducible switches, molecular mimicry, and bio hybrid microrobots to convert strains into delivery vehicles for cytokines, checkpoint inhibitors, and neoantigens.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353350,1790169719,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Review  \nPUBLISHED 28 July 2026  \nDOI 10.3389/fimmu.2026.1878878  \nOPEN ACCESS  \nEDITED BY  \nTao Sun,  \nFudan University, China  \nREVIEWED BY  \nAude Fahrer,  \nAustralian National University, Australia Zhiming Liu,  \nSouth China Normal University, China  \n*CORRESPONDENCE  \nJinhu Guo  \n[jinhuguo916@163.com](jinhuguo916@163.com)  \nRECEIVED 12 May 2026  \nREVISED 19 June 2026  \nACCEPTED 21 July 2026  \nPUBLISHED 28 July 2026  \nCITATION  \nGuo J, Li Y, Yang Y and Wang B (2026) Molecular mechanisms of bacteriamediated cancer immunotherapy:  \nfrom intratumoral microbiota to engineered therapeutics.  \nFront. Immunol. 17:1878878 .  \ndoi: 10.3389/fimmu.2026.1878878  \nCOPYRIGHT  \n© 2026 Guo, Li, Yang and Wang. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMolecular mechanisms of bacteria-mediated cancer immunotherapy: from intratumoral microbiota to engineered therapeutics  \nJinhu Guo *, Yimeng Li, Yue Yang and Bobo Wang Yan ’an Medical College, Yan’an University, Yan’an, Shaanxi, China  \nImmunotherapy has redeﬁned oncology, yet its efﬁcacy remains constrained by low response rates, primary or acquired resistance, immune-related toxicities, and escalating costs. Bacteria-mediated cancer immunotherapy (BCIT), which exploits the intratumoral microbiota as a programmable immunotherapeutic platform, has therefore emerged as a promising strategy. Although anecdotal links between infection and tumor regression were documented over four millennia ago, the molecular underpinnings of BCIT have only recently become accessible through synthetic biology, single-cell sequencing, and gnotobiotic modeling. Here we synthesize current knowledge on how intratumoral bacteria either enhance or suppress malignancy via genotoxicity, epigenetic reprogramming, metabolic competition, and modulation of the tumor-immune interface. We dissect cutting-edge engineering approaches—quorum-sensing circuits, thermo-inducible switches, molecular mimicry, and bio hybrid microrobots, that convert commensal or attenuated pathogenic strains into precision delivery vehicles for cytokines, checkpoint inhibitors, and neoantigens. Finally, we critically evaluate translational bottlenecks (safety, pharmacokinetics, regulatory science, inter-patient heterogeneity) and propose an AI-guided, microbiome-integrated framework to accelerate clinical translation . This Review provides a conceptual framework for harnessing living therapeutics to convert immunologically “cold” tumors into “hot”, therapy-sensitive lesions, and discusses key directions for future microbiome-driven oncology trials.  \nKEYWORDS  \nbacteria-mediated cancer immunotherapy, cancer, immunotherapy, intratumoral microbiota, tumor-immune interface  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nProgress in the ﬁeld of cancer immunotherapy is enhancing the potential for curative outcomes and broadening the spectrum of cancers that respond to these innovative therapeutic approaches, thereby instilling renewed optimism among patients (1) . However, many cancers still do not respond to immunotherapies. For example, 40-65% of melanoma patients and 45-85% of nonsmall-cell lung cancer (NSCLC) patients have innate resistance to immune-checkpoint inhibitors (ICIs), despite these tumors being among the most responsive (2–5) . This underscores the need for more effective treatment strategies to tackle resistance.  \nThe human microbiota signiﬁcantly impacts tumorigenesis and cancer therapy (6–8) . While gut microbiota research dominates these ﬁelds, emerging insights highlight the existence and path","cbCaiojWl3S8rshB","https://ap.wps.com/l/cbCaiojWl3S8rshB","pdf",6199416,25,"English","# Introduction\n## Intratumoral microbiota and therapy resistance\n## Methods to study intratumoral microbiota\n## Live bacteria and precision immunotherapeutic engineering","[{\"question\":\"What limits the effectiveness of cancer immunotherapy addressed in the Review?\",\"answer\":\"The Review highlights low response rates, primary or acquired resistance, immune-related toxicities, and escalating costs as key constraints.\"},{\"question\":\"How do intratumoral bacteria influence cancer and the immune environment?\",\"answer\":\"They can enhance or suppress malignancy through pathways including genotoxicity, epigenetic reprogramming, metabolic competition, and modulation of the tumor-immune interface.\"},{\"question\":\"What engineering approaches does the Review discuss for bacterial-based immunotherapy?\",\"answer\":\"It discusses engineering strategies such as quorum-sensing circuits, thermo-inducible switches, molecular mimicry, and bio hybrid microrobots to convert strains into delivery vehicles for cytokines, checkpoint inhibitors, and neoantigens.\"}]","Molecular mechanisms of bacteria-mediated cancer immunotherapy - from intratumoral microbiota to engineered therapeutics | PDF",1790104838,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/933e2a004f8ea28894709ee625fe2913.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14b30c57af8f4f3d751bc1085932479d.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c43e63823e780983bd325baab2ec9a78.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0555f3bf34fffaecd24ca823e71f784.webp",980,1385]